Related Experiment Videos
Microarray and protein analysis of human pterygium.
Molykutty John-Aryankalayil1, Nicholas Dushku, Cynthia J Jaworski
1National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA. aryankalayilm@mail.nih.gov
Molecular Vision
|February 1, 2006
Summary
This study identified 34 genes involved in pterygium development, including increased fibronectin and lipocalin 2 (NGAL). These findings shed light on the molecular mechanisms of this sunlight-related eye condition.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Pterygium is a common, sunlight-induced ocular surface lesion that can impair vision.
- Understanding the genetic basis of pterygium is crucial for developing effective treatments.
Purpose of the Study:
- To identify genes associated with pterygium pathogenesis by analyzing global gene expression profiles.
- To compare gene expression in pterygium tissue with autologous conjunctiva, limbal, and corneal tissues.
Main Methods:
- Oligonucleotide microarray hybridization was employed to compare gene expression between pterygium and conjunctiva.
- Reverse transcription polymerase chain reaction (RT-PCR), western blot, and immunohistochemistry were used for further gene characterization.
Main Results:
- Thirty-four genes showed significant expression differences (≥2 fold) between pterygium and conjunctiva.
- Increased expression of fibronectin, macrophage-inflammatory protein-4 (MIP-4), and lipocalin 2 (NGAL) was observed in pterygium.
- Fibronectin and MIP-4 were elevated in pterygium compared to limbus, cornea, and conjunctiva, with MIP-4 found throughout the pterygium tissue.
Conclusions:
- The study identified novel and known genes related to extracellular matrix, inflammation, angiogenesis, fibrosis, and oncogenesis in pterygium.
- Increased lipocalin 2 expression in pterygium correlates with elevated matrix metalloproteinases (MMPs), supporting previous findings.
- Gene expression patterns in pterygium provide insights into its pathogenesis and potential therapeutic targets.